296 related articles for article (PubMed ID: 12393901)
21. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
22. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
[TBL] [Abstract][Full Text] [Related]
23. Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells.
Clarke P; Meintzer SM; Moffitt LA; Tyler KL
J Biol Chem; 2003 May; 278(20):18092-100. PubMed ID: 12637521
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB
Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
[TBL] [Abstract][Full Text] [Related]
25. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
[TBL] [Abstract][Full Text] [Related]
26. Reovirus-induced apoptosis is mediated by TRAIL.
Clarke P; Meintzer SM; Gibson S; Widmann C; Garrington TP; Johnson GL; Tyler KL
J Virol; 2000 Sep; 74(17):8135-9. PubMed ID: 10933724
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.
Kimura K; Gelmann EP
J Biol Chem; 2000 Mar; 275(12):8610-7. PubMed ID: 10722700
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
29. Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways.
Jones BE; Lo CR; Liu H; Srinivasan A; Streetz K; Valentino KL; Czaja MJ
J Biol Chem; 2000 Jan; 275(1):705-12. PubMed ID: 10617670
[TBL] [Abstract][Full Text] [Related]
30. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
[TBL] [Abstract][Full Text] [Related]
31. Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction.
Krippner-Heidenreich A; Tübing F; Bryde S; Willi S; Zimmermann G; Scheurich P
J Biol Chem; 2002 Nov; 277(46):44155-63. PubMed ID: 12215450
[TBL] [Abstract][Full Text] [Related]
32. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
[TBL] [Abstract][Full Text] [Related]
33. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
[TBL] [Abstract][Full Text] [Related]
34. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
35. Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes.
Schwabe RF; Uchinami H; Qian T; Bennett BL; Lemasters JJ; Brenner DA
FASEB J; 2004 Apr; 18(6):720-2. PubMed ID: 14766793
[TBL] [Abstract][Full Text] [Related]
36. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas.
Jayasooriya RGPT; Moon DO; Park SR; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY
Environ Toxicol Pharmacol; 2013 Sep; 36(2):303-310. PubMed ID: 23708311
[TBL] [Abstract][Full Text] [Related]
37. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
[TBL] [Abstract][Full Text] [Related]
38. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng CP; Bonavida B
Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
[TBL] [Abstract][Full Text] [Related]
39. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
40. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
